Viracta Therapeutics, Inc.
VIRX
Revenue
120.00k
▼-117.00k▼-49.37%
24 Months ChangeAssets
21.96M
▼-9.36M▼-29.90%
3 Months ChangeLiabilities
28.58M
▼-76.00k▼-0.2653%
3 Months ChangeFree Cash Flow
-11.46M
▼-11.46M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-14
Form 10-Q
ID: 0000950170-24-096982
2024-08-14
Form 8-K
ID: 0000950170-24-096648
2024-07-29
Form 8-K
ID: 0000950170-24-087020
2024-06-20
Form 8-K
ID: 0001193125-24-164449
2024-05-31
Form 8-K
ID: 0000950170-24-067393
2024-05-14
Form 8-K
ID: 0000950170-24-059668
2024-05-09
Form 10-Q
ID: 0000950170-24-057250
2024-05-09
Form 8-K
ID: 0000950170-24-057130
2024-04-09
Form 8-K
ID: 0000950170-24-043014
2024-03-20
Form 8-K
ID: 0000950170-24-034230